封面
市場調查報告書
商品編碼
1935162

可程式輸液幫浦和導管市場:按產品類型、按模式、按應用、按通道類型、按最終用戶、按地區分類

Programmable Infusion Pumps and Catheters Market, By Product Type, By Modality, By Application, By Channel Type, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 154 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2026 年,可程式輸液幫浦和導管市場價值將達到 139.05 億美元,預計到 2033 年將達到 206.5 億美元,2026 年至 2033 年的複合年成長率為 5.8%。

報告內容 報告詳情
基準年: 2025 2026年市場規模: 139.05億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
預測期(2026-2033年)複合年成長率: 5.80% 2033 年的預測值: 206.5億美元

輸液幫浦根據其工作原理進行分類。例如,在注射式幫浦中,液體儲存在注射器儲液器中,液體的輸送由可移動的活塞控制。而彈性體幫浦則將液體儲存在可拉伸的氣囊儲液器中,流速由氣囊彈性壁的壓力控制。這種由應用特性驅動的產品多樣性預計將在預測期內對全球可編程輸液幫浦和導管市場的成長產生積極影響。

市場動態

可程式設計輸液幫浦相對於不可程式設計輸液幫浦的優勢預計將在預測期內推動全球可程式輸液幫浦和導管市場的成長。例如,在靜脈輸液中使用不可程式設計輸液幫浦會帶來劑量控制不准和漏輸等問題。例如,根據美國國家生物技術資訊中心 (NCBI) 的數據,2015 年 3 月至 4 月在衣索比亞進行的一項關於靜脈給藥錯誤 (MAE) 的研究報告顯示,在 134 例病例中,MAE 的發生率為 46%,其中漏輸是最常見的錯誤。然而,可程式輸液幫浦的高成本預計將在一定程度上阻礙全球市場的成長。

本次調查的主要特點

  • 本報告對全球可程式輸液幫浦和導管市場進行了詳細分析,以 2025 年為基準年,給出了預測期(2026-2033 年)的市場規模和複合年成長率(%)。
  • 它還重點介紹了各個細分市場的潛在商機,並為該市場提出了一個有吸引力的投資提案矩陣。
  • 該研究還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、區域前景以及主要企業採取的競爭策略的重要見解。
  • 本報告根據以下參數對全球可程式輸液幫浦和導管市場的主要企業進行了分析:公司概況、財務績效、產品系列、地理分佈、分銷策略、關鍵發展和策略。
  • 本報告的研究結果將使負責人和經營團隊能夠透過技術升級、市場擴張和行銷策略,就未來的產品發布做出明智的決策。
  • 這份全球可程式輸液幫浦和導管市場報告的目標受眾是該行業的各種相關人員,包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過各種策略矩陣輕鬆做出決策,這些矩陣用於分析全球可編程輸液幫浦和導管市場。

目錄

第1章 研究目標與假設

  • 調查目的
  • 先決條件
  • 簡稱

第2章 市場範圍

  • 報告概述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章 市場動態、監理及趨勢分析

  • 市場動態
    • 促進要素
    • 抑制因素
    • 市場機遇
    • 影響分析
  • 技術演進
  • PEST分析
  • 管道分析
  • 波特分析

4. 2026-2033年全球可程式輸液幫浦和導管市場(依產品類型分類)

  • 容積式泵
  • 注射式幫浦
  • 腸內泵
  • 胰島素幫浦
  • 植入式幫浦
  • 患者自控鎮痛泵
  • 水泵配件

5. 2026-2033年全球可程式輸液幫浦及導管市場(依輸液分類)

  • 攜帶式的
  • 固定式

6. 2026-2033年全球可程式輸液幫浦和導管市場(依應用領域分類)

  • 腫瘤學
  • 小兒科/新生兒科
  • 疼痛管理
  • 消化系統
  • 血液學
  • 糖尿病

7. 2026-2033年全球可程式輸液幫浦和導管市場(依通道類型分類)

  • 單通道
  • 多通路娛樂

8. 2026-2033年全球可程式輸液幫浦和導管市場(依最終用戶分類)

  • 醫院
  • 門診部
  • 居家醫療
  • 診所
  • 其他

9. 2026-2033年全球可程式輸液幫浦和導管市場(按地區分類)

  • 北美洲
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 亞太其他地區
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他拉丁美洲國家
  • 中東
  • GCC
  • 以色列
  • 其他中東國家
  • 非洲
  • 中非
  • 南非
  • 北非

第10章 競爭格局

  • 公司簡介
    • ICU Medical, Inc.
    • Smiths Group plc.
    • Baxter International Inc.
    • Fresenius Se &Co. KGaA
    • Johnson &Johnson
    • Medtronic plc.
    • Becton, Dickinson and Company
    • Terumo Corporation
    • B. Braun Melsungen AG
    • Moog Inc.

第11章各節

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI2565

Programmable Infusion Pumps And Catheters Market is estimated to be valued at USD 13,905 Mn in 2026 and is expected to reach USD 20,650 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.8% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 13,905 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 5.80% 2033 Value Projection: USD 20,650 Mn

Infusion pumps are classified depending on the mode of their operation. For instance, in a syringe pump, fluid is held in the syringe reservoir and the fluid delivery is controlled by a moveable piston, whereas in an elastomeric pump, a stretchable balloon reservoir contains fluid and its flow rate is controlled by the pressure from elastic walls of the balloon. Such product diversity, driven by the nature of its intended use, is expected to have a positive impact on global programmable infusion pumps and catheters market growth over the forecast period.

Market Dynamics

Advantages offered by programmable infusion pumps over non-programmable infusion pumps is expected to drive the global programmable infusion pumps and catheters market growth during the forecast period. For instance, the use of non-programmable infusion pumps for intravenous infusion is associated with problems such as uncontrolled dosing, possibility of missing dosage of medication, and others. For instance, according to National Center for Biotechnology Information (NCBI), in a study conducted on intravenous medication administration errors (MAEs) in Ethiopia, from March 2015 to April 2015, out of 134 cases the rate of MAE was reported to be 46%, with missed dosage being the most common error. However, high costs of programmable infusion pumps is expected to restrain global programmable infusion pumps market growth up to certain extent.

Key features of the study

  • This report provides in-depth analysis of global programmable infusion pumps and catheters market, and provides market size (USD Mn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2026-2033), considering 2025 as the base year
  • It elucidates potential revenue opportunities across different segments and presents an attractive investment proposition matrix for this market
  • This study also provides key insights into market drivers, restraints, opportunities, new product launches or approvals, regional outlooks, and competitive strategies adopted by leading players
  • It profiles leading players in the global programmable infusion pumps and catheters market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key companies covered as a part of this study include ICU Medical, Inc., Smiths Group plc., Baxter International Inc., Fresenius Se & Co. KGaA, Johnson & Johnson, Medtronic PLC, Becton, Dickinson and Company, Terumo Corporation, B. Braun Melsungen AG, and Moog Inc.
  • Insights from this report would allow marketers and management authorities of the companies to make informed decision regarding their future product launches, by technology up-gradation, market expansion, and marketing tactics
  • The global programmable infusion pumps and catheters market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global programmable infusion pumps and catheters market

Market Segmentation

  • Product Type Insights (Revenue, USD Mn, 2026 - 2033)
    • Volumetric Pumps
    • Syringe Pumps
    • Enteral Pumps
    • Insulin Pumps
    • Implantable Pumps
    • Patient Controlled Analgesia Pumps
    • Pump Accessories
  • Modality Insights (Revenue, USD Mn, 2026 - 2033)
    • Portable
    • Stationary
  • Application Insights (Revenue, USD Mn, 2026 - 2033)
    • Oncology
    • Pediatrics/Neonatology
    • Pain
    • Gastroenterology
    • Hematology
    • Diabetes
  • Channel Type Insights (Revenue, USD Mn, 2026 - 2033)
    • Single Channel
    • Multi-channel
  • End User Insights (Revenue, USD Mn, 2026 - 2033)
    • Hospitals
    • Ambulatory Clinics
    • Homecare
    • Clinics
    • Others
  • Regional Insights (Revenue, USD Mn, 2026 - 2033)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • ICU Medical, Inc.
    • Smith's Group plc.
    • Baxter International Inc.
    • Fresenius Se & Co. KGaA
    • Johnson & Johnson
    • Medtronic plc.
    • Becton
    • Dickinson and Company
    • Terumo Corporation
    • Braun Melsungen AG
    • Moog Inc.

Table of Contents

1. Research Objective and assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Modality
    • Market Snippet, By Application
    • Market Snippet, By Channel Type
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
  • Technological Evolution
  • PEST Analysis
  • Pipeline Analysis
  • Porter's Analysis

4. Global Programmable Infusion Pumps and Catheters Market, By Product Type, 2026-2033 (USD Mn)

  • Introduction
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Volumetric Pumps
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Syringe Pumps
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Enteral Pumps
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Insulin Pumps
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Implantable Pumps
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Patient Controlled Analgesia Pumps
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Pump Accessories
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends

5. Global Programmable Infusion Pumps and Catheters Market, By Modality, 2026-2033 (USD Mn)

  • Introduction
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Portable
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Stationary
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends

6. Global Programmable Infusion Pumps and Catheters Market, By Application, 2026-2033 (USD Mn)

  • Introduction
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Oncology
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Pediatrics/Neonatology
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Pain
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Gastroenterology
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hematology
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Diabetes
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends

7. Global Programmable Infusion Pumps and Catheters Market, By Channel Type, 2026-2033 (USD Mn)

  • Introduction
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Single Channel
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Multi-channel
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends

8. Global Programmable Infusion Pumps and Catheters Market, By End User, 2026-2033 (USD Mn)

  • Introduction
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hospitals
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Ambulatory Clinics
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Homecare
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Clinics
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Others
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends

9. Global Programmable Infusion Pumps and Catheters Market, By Regions, 2026-2033 (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2033
  • North America
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Product Type, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Modality, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Application, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Channel Type, 2026-2033 (USD Mn)
    • Market Size and Forecast, By End User, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Country, 2026-2033 (USD Mn)
      • U.S.
      • Canada
  • Europe
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Product Type, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Modality, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Application, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Channel Type, 2026-2033 (USD Mn)
    • Market Size and Forecast, By End User, 2026-2033 (USD Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Product Type, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Modality, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Application, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Channel Type, 2026-2033 (USD Mn)
    • Market Size and Forecast, By End User, 2026-2033 (USD Mn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Product Type, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Modality, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Application, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Channel Type, 2026-2033 (USD Mn)
    • Market Size and Forecast, By End User, 2026-2033 (USD Mn)
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Product Type, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Modality, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Application, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Channel Type, 2026-2033 (USD Mn)
    • Market Size and Forecast, By End User, 2026-2033 (USD Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Product Type, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Modality, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Application, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Channel Type, 2026-2033 (USD Mn)
    • Market Size and Forecast, By End User, 2026-2033 (USD Mn)
  • Central Africa
  • South Africa
  • North Africa

10. Competitive Landscape

  • Company Profiles
    • ICU Medical, Inc.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Smiths Group plc.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Baxter International Inc.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Fresenius Se & Co. KGaA
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Johnson & Johnson
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Medtronic plc.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Becton, Dickinson and Company
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Terumo Corporation
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • B. Braun Melsungen AG
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Moog Inc.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies

11. Section

  • References
  • Research Methodology
  • About us and Sales Contact